|
|
 |
|
Viewing report
|
|
|
|
European Market for Nutritional Solutions in Immune and Antihypertensive Health
Frost & Sullivan, March 2011, Pages: 210
This research service tracks the key trends in the European immune and antihypertensive health ingredients markets, while also quantifying most of the ingredient markets in terms of revenue and unit shipment. Key companies and their position in their relevant market segments is analyzed. It provides revenue forecasts at a total market and segment level from 2010 to 2016, challenges affecting the industry, factors driving growth of the market, competitive scenario and opportunities that participants can look forward to during the forecast period
Research Overview
This Frost & Sullivan research service titled European Market for Nutritional Solutions in Immune and Antihypertensive Health analyses the market drivers and restraints and industry challenges. The study forecasts the revenues and volumes of most of the ingredient segments. In this research, Frost & Sullivan’s expert analyst thoroughly examines the following segments: immune health ingredients comprising yeast beta-glucan, prebiotics, probiotics, Vitamin C, zinc and medicinal mushroom ingredients; antihypertensive health ingredients comprising dairy peptides, natural vitamin K2, L-carnitine and grape seed extract.
Market Overview
Accent on Preventive Healthcare Drives the European Market for Nutritional Solutions in Immune and Antihypertensive Health
The rising incidence of problems related to high blood pressure and weak immune system as well as the gravitation toward preventive healthcare is driving the European market for nutritional solutions in immune and antihypertensive health. The swine flu epidemic that hit Europe and the United States had boosted consumer interest in maintaining a healthy immune system. Ingredients manufacturers in this space are cashing in on the growing awareness of the potential of immune health ingredients in preventing flu-like symptoms and respiratory infections. In particular, health ingredients that offer cholesterol- and blood pressure- lowering benefits are poised to pick up traction. Although blood pressure-lowering ingredients are not currently very popular, they are expected to slowly catch up due to improving consumer awareness. Studies reveal that approximately 5 million Europeans suffer from heart failure, and nearly 860,000 new cases are reported each year. Prevalence rates vary from country to country, in the range of three and twenty cases per thousand members of the population. (Source: HEBW, Coronary Heart Disease). “The sheer extent at which cardiovascular disease (CVD) affects the population in Europe, including those with hypertension, offers significant opportunities for ingredient manufacturers,” notes the analyst of this research service.
Although the prospects for the market are bright, there are some challenges hampering its progression. Rigorous competition is prevalent among the plethora of immune health ingredients available in the market. Most of these ingredients are positioned for other health benefits as well. For instance, probiotics and prebiotics are projected primarily as providers of digestive health benefits rather than positive immune health advantages. Such a scenario creates confusion in the minds of consumers and dissuades them from buying such ingredients. Similarly, antihypertensive health ingredients market is faced with the challenge of competing with the traditional modes of lowering blood pressure such as exercise, weight management, salt reduction, and drugs such as diuretics, beta-blockers, angiotensive converting enzyme (ACE) inhibitors, calcium channel blockers or vasodilators. “Besides, regulatory issues pertaining to health claims are limiting innovation and growth in the European Market for Nutritional Solutions in Immune and Antihypertensive Health, like any other health ingredient market in the region,” notes Pasricha. Health claim regulations in Europe are getting increasingly complex and vague with the Nutrition and Health Claims Regulation adopted in 2006. The regulation was brought in place to ensure that consumers are not misled by unsubstantiated, exaggerated or false claims about foods or food ingredients. A great deal of vagueness surrounds the most appropriate articles (13.1, 13.5 or 14) under nutrition and health claim regulation for various types of claims. Such loopholes have caused poor understanding of the regulation by the food industry stakeholders and, consequently, resulted in rejection of a majority of the submitted applications.
Steps by European Food Safety Agency (EFSA) directed at bringing clarity on the criteria required for positive scientific opinion from the organisation with respect to health claims is likely to encourage innovation in the market. “Manufacturers must make efforts to ramp up awareness levels among consumers about the scientific-backing and the mode of action of their immune and anti-hypertensive health ingredients,” says the analyst. “Proactive research initiatives by manufacturers supporting their ingredients efficacy, empowered with apt promotional efforts could prove instrumental in increasing consumer/customer trust and acceptance in the high potential European immune and antihypertensive health ingredients market.”
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Immune health ingredients:
- Yeast beta-glucan
- Prebiotics
- Probiotics
- Vitamin C
- Zinc
- Mushroom ingredients
- Antihypertensive health ingredients:
- Dairy peptides
- Natural vitamin K2
- L-carnitine
- Grape seed extract
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
